The New England journal of medicine
Evolocumab in Patients with Cardiovascular Disease.
A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Myocarditis with Immune Checkpoint Blockade.
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
Cardiovascular Toxic Effects of Targeted Cancer Therapies.
Cancer-drug discovery and cardiovascular surveillance.
The cardiovascular perils of cancer survivorship.
Clinical problem-solving. The heart of the matter.
Reversible cardiomyopathy associated with sunitinib and sorafenib.
